See also this year's filing and all EDGAR filings for this company.
PDF Report 0001135906_2015_Epirus_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Regenerx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001135906, Epirus Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 23,018,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,468,000 |
| 2 | PropertyPlantAndEquipmentNet | 704,000 |
| 3 | remainder_Assets | 2,199,000 |
| 4 | LiabilitiesCurrent | 7,376,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 19,275,257 |
| 9 | ResearchAndDevelopmentExpense | 11,129,838 |
| 10 | remainder_Expenses | 6,910,596 |
| 11 | remainder_Revenues | -2,489,216 |
| 12 | remainder_NetIncome | -16,057,363 |
| 13 | remainder_ComprehensiveNetIncome | -4,880 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 51,389,000 |
| 1 | Liabilities | 7,376,000 |
| 2 | Expenses | 37,315,691 |
| 3 | Revenues | -2,489,216 |
| 4 | StockholdersEquity | 44,013,000 |
| 5 | NetIncome | -55,862,270 |
| 6 | ComprehensiveNetIncome | -55,864,710 |
| 7 | BaseVar | 57,316,075 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.36 |
| 9 | EconomicCapitalRatio | 2.58 |
Edgar->Model Mapping
Feature Distribution
Change over Time
